Delayed emesis following anticancer chemotherapy

被引：25

作者：

Kris, MG ^{[1
]}

Roila, F

De Mulder, PHM

Marty, M

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10021 USA

[2] Cornell Univ, Coll Med, New York, NY USA

[3] Monteluce Policlin, Div Med Oncol, I-06122 Perugia, Italy

[4] Univ Nijmegen Hosp, Div Med Oncol 550, NL-6510 HB Nijmegen, Netherlands

[5] Hop St Louis, Dept Med Oncol, F-75475 Paris 10, France

来源：

SUPPORTIVE CARE IN CANCER | 1998年 / 6卷 / 03期

关键词：

cancer; chemotherapy; delayed emesis; antiemetic therapy;

D O I：

10.1007/s005200050158

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Delayed emesis is a distinct syndrome where vomiting begins or persists 24 or more hours after chemotherapy. It is more Likely to occur when the stimulus for emesis is strong and/or acute vomiting is poorly controlled. The pathophysiology appears different than that which causes acute emesis, The literature reporting clinical trials to prevent delayed nausea and vomiting are presented. The best ways of preventing delayed emesis following anticancer chemotherapy are discussed.

引用

页码：228 / 232

页数：5

共 36 条

[1]

Basurto C, 1995, ANN ONCOL, V6, P805

[2]

CLARK R, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P257

[3] ANTAGONISM OF SEROTONIN-S3 RECEPTORS WITH ONDANSETRON PREVENTS NAUSEA AND EMESIS INDUCED BY CYCLOPHOSPHAMIDE-CONTAINING CHEMOTHERAPY REGIMENS [J].